Overexpression of Bcl-2, Bcl-xL, and survivin in several cancers overcomes severe tumor environments and facilitates cancer progression, chemotherapeutic resistance and higher rate of recurrence [15,17,18,38,39]. Here, BIRC5 is linked to cancer.